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Peripheral tolerance prevents self-reactive T cells 
that escape thymic negative selection from caus-
ing autoimmunity. Intrinsic mechanisms of pe-
ripheral tolerance lead to anergy (Redmond et al., 
2005) or deletion (Kurts et al., 1997; Hernandez 
et al., 2001; Liu and Lefrançois, 2004) when 
CD8 T cells encounter their cognate tissue- 
restricted self-antigens. In the prevailing model 
of this process, these antigens are acquired by 
quiescent  tissue-resident  DCs,  which  then 
migrate to regional LN and cross-present them 
to naive T cells (Hawiger et al., 2001; Belz et al., 
2002; Waithman et al., 2007). This presentation 
is limited to LN draining the tissues in which 
the self-antigen is expressed. Recently, we 
and others have described an alternative mech-
anism in which CD8 T cell peripheral tolerance 
is induced by LN-resident cells  that  directly 
express  otherwise  tissue-restricted  proteins   
(Lee et al., 2007; Nichols et al., 2007; Gardner   
et al., 2008). Thus far, two nonoverlapping LN 
stromal cell populations have been associated 
with this mechanism. Using an antigen ex-
pressed under the control of the autoimmune 
regulator (Aire) promoter, Gardner et al. (2008) 
implicated a subset of EpCAM+ gp38neg Aire+ 
LN stromal cells. Two other studies using anti-
gens expressed under the control of intestinal 
epithelial and enteric glial cell promoters impli-
cated UEA-1+ LN stromal cells (Lee et al., 
2007; Magnusson et al., 2008). However, these 
studies relied on transgenic antigens expressed 
under the control of tissue-specific promoters, 
creating uncertainty about whether the ectopic 
expression observed in LN cells is physiologi-
cally relevant.
We have evaluated self-tolerance to a model 
antigen expressed in its native genetic context: 
the mouse homologue of a human HLA-A*0201- 
restricted  epitope  from  the  endogenously  en-
coded protein tyrosinase (Tyr369; Colella et al., 
2000). This epitope is presented in the context 
of  a  transgenic  HLA-A*0201-based  chimeric 
MHC I molecule (AAD). The level of expression 
of AAD is comparable to that of endogenous 
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Peripheral immune tolerance is generally thought to result from cross-presentation of 
tissue-derived proteins by quiescent tissue-resident dendritic cells to self-reactive T cells 
that have escaped thymic negative selection, leading to anergy or deletion. Recently, we 
and others have implicated the lymph node (LN) stroma in mediating CD8 T cell peripheral 
tolerance. We demonstrate that LN-resident lymphatic endothelial cells express multiple 
peripheral tissue antigens (PTAs) independent of the autoimmune regulator (Aire). They 
directly present an epitope derived from one of these, the melanocyte-specific protein 
tyrosinase, to tyrosinase-specific CD8 T cells, leading to their deletion. We also show that 
other LN stromal subpopulations express distinct PTAs by mechanisms that vary in their 
Aire dependence. These results establish lymphatic endothelial cells, and potentially other 
LN-resident cells, as systemic mediators of peripheral immune tolerance.
© 2010 Cohen et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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In this paper, we have identified the cell that directly   
expresses  the  Tyr369  epitope  as  an  LN-resident  lymphatic   
endothelial cell. We have established that these cells express 
both tyrosinase and another tissue-restricted mRNA inde-
pendent of Aire. Finally, we show that other subpopulations 
of LN stromal cells express distinct peripheral tissue tran-
scripts, which differ in their dependence on Aire. Our results 
suggest that ectopic expression of tissue-specific transcripts by 
multiple subsets of LN stromal cells is of general importance 
in establishing peripheral tolerance.
RESULTS AND DISCUSSION
We previously showed that FH T cells undergo deletional 
tolerance in all LN but not in either thymus or spleen (Nichols 
et al., 2007; Fig. S1). Tolerance is not mediated by conven-
tional DC or Langerhans cells in the periphery but instead 
depends on radioresistant LN-resident cells that express   
tyrosinase directly (Nichols et al., 2007). To identify the radio-
resistant cells expressing tyrosinase, pooled LN of tyrosinase-
expressing B6 mice were collagenase digested to yield single 
cell suspensions and CD45+ and CD45neg subsets were enriched 
mouse MHC I molecules (Newberg et al., 1996). Interest in 
this epitope is based on the fact that it and other epitopes de-
rived from pigmentation proteins are broadly recognized by   
T cells from melanoma and vitiligo patients, despite being un-
modified self-proteins expressed in melanocytes (Slingluff et al., 
2006). To study CD8 T cell tolerance induction to Tyr369, we 
generated a transgenic mouse expressing a TCR specific   
for Tyr369:AAD, designated “FH.” We previously demon-
strated that Tyr369 is constitutively presented in both peripheral 
and mesenteric LNs but not spleen, leading to abortive prolif-
eration and deletion of FH cells. Importantly, Tyr369 is not 
cross-presented by either radiosensitive DCs or radioresistant 
Langerhans cells under noninflammatory conditions, excluding 
cross-tolerance as an operative mechanism. Although tyrosinase 
expression  is  normally  confined  to  melanocytes  and  retinal   
pigment epithelial cells, where it is involved in melanin bio-
synthesis, we found tyrosinase messenger RNA (mRNA) in the 
lymphoid compartments where CD8 T cell deletion occurred. 
This suggested that direct presentation of tyrosinase by a radio-
resistant LN-resident cell is entirely responsible for tolerance to 
this endogenous melanocyte differentiation Ag.
Figure 1.  gp38+CD31+ LN stromal cells express and present Tyr369 in an Aire-independent manner. (a) Tyrosinase (Tyr) and -actin expression in 
CD45neg and CD45+ LN populations from B6 and albino animals was determined using 40-cycle RT-PCR. Data shown are representative of four indepen-
dent experiments. (b) Proliferation of CFSE-labeled naive Thy1.2+ FH T cells co-cultured with Thy1.1+ CD45neg (black bars) or CD45+ (white bars) cells puri-
fied from the LNs of tyrosinase+ and albino animals was assessed after 86 h. Left, representative experiment; right, summary data for two independent 
experiments. (c) LN stromal cell populations defined based on expression of gp38 and CD31. The representative plot is gated on CD45neg cells. Numbers 
indicate percentage of total CD45neg cells. (d) Tyrosinase and -actin expression in CD45+ cells and four LN stromal cell subpopulations identified by dif-
ferential expression of gp38 and CD31. Purified populations were obtained by electronic cell sorting and 40-cycle RT-PCR was performed. Data shown are 
representative of six independent experiments. (e) Proliferation of CFSE-labeled naive Thy1.2+ FH T cells co-cultured with Thy1.1+ cells of the indicated 
purified LN stromal cell subpopulations from tyrosinase+ (black bars) and albino (white bars) animals was assessed after 86 h. Left, representative experi-
ment; right, summary data for three independent experiments. Error bars indicate SEM.JEM VOL. 207, April 12, 2010  683
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which we attribute to a small and variable number of con-
taminating gp38+CD31+ cells in different cell sorts. To estab-
lish the relevance of this tyrosinase expression, we co-cultured 
naive CFSE-labeled FH T cells with each LN stromal cell 
subpopulation from either AAD+tyrosinase+ or albino mice. 
The gp38+CD31+ subpopulation stimulated robust antigen-
specific proliferation, whereas the others did not (Fig. 1 e). 
This proliferation was physiologically relevant, as the expres-
sion level of AAD was comparable to that of endogenous 
MHC class I molecules (Fig. S2). Thus, gp38+CD31+ LN 
stromal cells are the only subpopulation that both expresses ty-
rosinase and presents Tyr369 to FH T cells.
A previous study demonstrated expression of several 
melanocyte differentiation proteins by LN-resident cells and 
concluded that they were of the melanocyte lineage (Schuler 
et al., 2008). However, neither gp38 nor CD31 was detectible 
on melanocytes in the avascular epidermis (Fig. 2). In addition, 
although epidermal melanocytes expressed tyrosinase strongly, 
only a small number of cells in LN stained with anti-tyrosinase 
antibody, and a comparable number of these cells was also 
observed in albino mice with a full deletion of the tyrosinase 
gene (not depicted; Nichols et al., 2007). These data strongly 
suggest that the gp38+CD31+ LN stromal cells, the only subset 
which expresses tyrosinase, are not of melanocytic origin and 
that the level of tyrosinase protein expression in LN stromal 
cells is low. LN stromal cells include a subpopulation identified 
using magnetic beads. RT-PCR of mRNA extracted from 
these cells reproducibly demonstrated that tyrosinase expres-
sion was confined to CD45neg LN stromal cells (Fig. 1 a). As 
expected, tyrosinase mRNA was not detected in the LN 
stromal cells of albino mice carrying a complete deletion of 
the tyrosinase gene. To assess the ability of LN stromal cells 
to present Tyr369, naive CFSE-labeled FH T cells were co-
cultured in vitro with AAD+ tyrosinase+ CD45neg or CD45+ 
LN  cells.  FH  T  cells  proliferated  when  co-cultured  with   
CD45neg LN cells but not with CD45+ LN cells (Fig. 1 b). 
This proliferation was antigen specific, as it was not induced 
by CD45neg LN cells from AAD+ albino mice. Thus, CD45neg 
LN cells express tyrosinase mRNA and, based on their ability 
to induce FH T cell proliferation in vitro, translate and pro-
cess tyrosinase protein for presentation in the context of 
MHC I molecules.
Consistent with an earlier study (Link et al., 2007), stain-
ing of CD45neg LN stromal cells for the cell surface markers 
CD31 and gp38 identified four different subpopulations 
(Fig. 1 c). Single cell suspensions of each of these subpop-
ulations were obtained by electronic cell sorting. RT-PCR 
demonstrated that tyrosinase was strongly and consistently 
expressed (six out of six experiments) in gp38+CD31+ LN 
stromal cells (Fig. 1 d). We inconsistently detected weak 
tyrosinase signals in either the gp38 or CD31 single-positive 
subsets (two and three out of six experiments, respectively), 
Figure 2.  The gp38+CD31+ LN stromal cells responsible for mediating tolerance to Tyr369 are not related to melanocytes. Immunofluores-
cence of a normal LN section (a and c) and epidermal ear sheets (b, d, and e) stained for the expression of LN stromal cell markers CD31 (100×; a and b) 
and gp38 (100×; c and d). Melanocytes in epidermal ear sheets were visualized by their tyrosinase staining (200×; e). Staining is representative of  
multiple magnifications and fields from two independent experiments consisting of two separate LNs and ears from three mice. Bars, 200 µm.684 Lymphatic endothelial cells induce tolerance | Cohen et al.
Figure 3.  The LN stromal cells responsible for mediating tolerance to Tyr369 have characteristics of lymphatic endothelial cells.  
(a) Staining of CD45neg LN stromal cells with antibodies against 10.1.1 and CD31. (b) RT-PCR for tyrosinase (Tyr) and -actin mRNA in CD45+  
cells and the indicated LN stromal cell subpopulations was evaluated as described in Fig. 1. Results shown are representative of five  
independent experiments. (c) Proliferation of CFSE-labeled naive Thy1.2+ FH T cells co-cultured with cells of the indicated LN stromal cell sub-
populations from Thy1.1+ tyrosinase+ and albino animals was assessed as in Fig. 1. Results are from two independent experiments performed  
with stromal cells isolated from six pooled mice each. (d, Top) Cells with dual staining of 10.1.1 and CD31 are located in the medulla (M) and in 
the interfollicular areas (arrows) but not in the T cell zone (T) or B cell follicles (B; 40×). Staining is representative of multiple magnifications  
and fields from two independent experiments consisting of two separate LNs from two mice. Bars, 1 mm. (d, Bottom) Higher magnification  
(400×) of the medulla (left) and the interfollicular region (right) showing intermingling of 10.1.1+ LEC and Thy1.1+ T cells. Staining is  
representative of multiple magnifications and fields from two independent experiments consisting of two separate LNs from one mouse.  
Bars, 400 µm.JEM VOL. 207, April 12, 2010  685
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as lymphatic endothelial cells (LECs) based on staining with 
the antibody 10.1.1 (Ruddell et al., 2003; Link et al., 2007), 
and these are included within the gp38+CD31+ subset (Link 
et al., 2007). To determine if the tyrosinase-expressing cells 
in  LN  were  LEC,  we  sorted  LN  stromal  cells  into 
10.1.1+CD31+, 10.1.1negCD31+, and 10.1.1negCD31neg sub-
populations (Fig. 3 a). Because of the species of the anti-
bodies, we were unable to determine if all of the gp38+   
CD31+ also stained positive for 10.1.1. However, virtually all 
10.1.1+ cells were positive for CD31. Moreover, their percent-
age of representation among LN stromal cells was comparable 
to that of the gp38+CD31+ population. In keeping with this, 
RT-PCR demonstrated that tyrosinase mRNA was expressed 
in 10.1.1+CD31+ cells but not in either 10.1.1negCD31+ or 
10.1.1negCD31neg cells (Fig. 3 b), although tyrosinase protein 
was not detected above background by flow cytometry or 
immunofluorescence (not depicted). In addition, naive CFSE-
labeled FH T cells proliferated robustly when co-cultured with 
10.1.1+CD31+ LEC but negligibly with the other two subpop-
ulations (Fig. 3 c). These results establish that the LN stromal 
cell that expresses tyrosinase and presents Tyr369 has lymphatic 
endothelial cell characteristics.
To confirm that 10.1.1+CD31+ cells were LECs and to 
determine how they were positioned with respect to T cells 
within the LN, we examined normal LN sections by immuno-
histochemistry. All 10.1.1+ cells costained strongly with CD31 
(Fig. 3 d) and the LEC-specific markers Lyve-1 (lymphatic 
vessel endothelial hyaluronan receptor 1) and Prox-1 (pros-
pero homeobox protein 1; Fig. S3). These 10.1.1+CD31+ 
LEC were localized predominantly to the medulla and the 
interfollicular zones and were largely absent from the T and 
B cell zones (Fig. 3 d). In both medulla and interfollicular 
zones, a relatively small number of individual T cells was 
found to interdigitate with the LEC (Fig. 3 d). These results 
demonstrate that LECs are advantageously positioned to toler-
ize potentially autoreactive naive T cells as they exit the LN 
but likely not in the T cell zone.
To determine if LECs have the potential to play a more 
general role in deletional tolerance, we examined the ex-
pression  of  another  melanocyte  differentiation  antigen, 
Mart1, and four other peripheral tissue antigens (PTAs) pre-
viously shown to be expressed in LN stromal cells (Lee et al., 
2007; Schuler et al., 2008). We found that A33, which is 
considered to be a definitive marker of intestinal epithelial 
cells (Johnstone et al., 2000), and the pancreatic polypeptide 
Ppy  were  also  predominately  expressed  in  LEC  that  had 
been purified using CD31 and either gp38 or 10.1.1 (Fig. 4 and 
Fig. S4). In contrast to tyrosinase, a second melanocyte dif-
ferentiation protein, Mart1, was not expressed in LEC. In-
stead, it was predominantly expressed in the gp38+CD31neg 
fibroblastic reticular cells (FRCs) and the 10.1.1negCD31neg 
population, which also contains FRC (Fig. 4). The expres-
sion of tyrosinase and Mart1 in mutually exclusive LN cell 
subpopulations further argues against a lineage of LN-resident 
melanoblasts (Schuler et al., 2008). Like Mart1, preproin-
sulin  2  (Ins2)  was  also  predominantly  expressed  in  the 
FRC (Fig. S4). Conversely, Gad67, which is normally ex-
pressed in pancreas and neuronal tissue (Yanagawa et al., 
1997), was not expressed in LEC but was also found in the 
gp38+CD31neg  FRC  and  the  10.1.1negCD31neg  population 
containing FRC, as well as gp38negCD31neg LN stromal cells 
and CD45+ LN cells (Fig. 4, a and b). Thus, FRC and one or 
more subsets of both gp38negCD31neg LN stromal cells and 
CD45+ LN express PTA distinct from those expressed by 
LEC. These data show that LEC and at least three other LN 
cell subpopulations have the potential to mediate tolerance to 
PTA from different tissues.
Aire has been shown to regulate the expression of many 
PTAs in medullary thymic epithelial cells (mTECs), which 
can result in the deletion of single-positive thymocytes (DeVoss 
et al., 2006). Aire is also expressed in LN (Mathis and Benoist, 
2009), and it was recently shown that EpCAM+gp38neg LN 
stromal cells expressing a tissue-specific transgene under the 
control of the Aire promoter induced CD8 T cell deletional 
tolerance (Gardner et al., 2008). However, Aire was not ex-
pressed in gp38+CD31+ or 10.1.1+CD31+ LEC, although it 
was expressed in CD45+ LN cells and gp38negCD31neg LN 
stromal cells (Fig. 4). In addition, both tyrosinase and A33 
continued to be expressed by LEC of Aire/ mice (Fig. 4). 
Aire/ AAD+ tyrosinase+ LEC also continued to induce the 
proliferation of FH cells in vitro (Fig. S5 a), and FH cells still 
underwent deletion after adoptive transfer into Aire/ 
AAD+ tyrosinase+ recipients (Fig. S5 b). Similarly, Aire was 
not expressed in gp38+CD31neg FRC, and expression of both 
Mart1 and Gad67 was maintained in Aire/ mice. How-
ever, the expression of Gad67 in both gp38negCD31neg and 
CD45+ populations was Aire dependent (Fig. 4). This parallels 
Figure 4.  LN stromal cell subsets express distinct groups of PTA 
that vary in their dependence on Aire. Tyrosinase (Tyr), A33, Mart1, 
Gad67, Aire, and -actin mRNAs were amplified by 40-cycle RT-PCR from 
the indicated subpopulations of LN stromal cells isolated from either 
C57BL/6 or Aire/ mice. Data from C57BL/6 mice sorted with gp38 and 
CD31 are representative of six independent experiments. Data from 
C57BL/6 mice sorted with 10.1.1 and CD31 are representative of three 
independent experiments. Data from Aire/ mice sorted with gp38 and 
CD31 are representative of two independent experiments.686 Lymphatic endothelial cells induce tolerance | Cohen et al.
subsets are capable of mediating self-tolerance. Nonetheless, 
these results collectively suggest that peripheral tolerance is 
mediated by the coordinated efforts of CD45+ and different 
LN stromal populations expressing distinct PTA that vary in 
their dependence on Aire.
Direct expression of PTA leading to tolerance has been 
most frequently associated with mTEC. In most cases, ex-
pression of PTA transcripts in mTEC has been shown to be 
Aire dependent (Derbinski et al., 2001, 2005). The expres-
sion of different subsets of PTA has been associated with the 
progressive differentiation of mTEC to express CD80 and 
Aire (Farr et al., 2002; Derbinski et al., 2005; Gillard and 
Farr, 2005; Kyewski and Klein, 2006; Yano et al., 2008). In 
contrast, our results show that different subsets of PTA are 
expressed by cell subpopulations in LN, at least some of which 
are not developmentally related. It is conceivable that sub-
sets of PTA-expressing cells in these compartments induce 
tolerance by distinct mechanisms or act on different subsets 
of lymphocytes. Our results also emphasize the importance 
of Aire-independent expression of other PTA in that it   
can lead to tolerance in LN. The Aire-independent expres-
sion of tyrosinase and A33 by LEC, and of Gad67 and   
Mart1 by FRC, suggests that an alternative transcriptional 
regulator controls the expression of these PTA. Recent work 
has established that Deaf1 (deformed epidermal autoregula-
tory factor 1), a member of the SAND transcription factor 
family which includes Aire, regulates expression of PTA in 
pancreatic LN (Yip et al., 2009). Although we have found 
Deaf1 in all of the CD45neg subsets identified in this paper 
(unpublished data), it is not yet clear to what extent it regu-
lates their expression of various PTA.
DC-mediated cross-presentation of self-antigen has been 
the established paradigm for peripheral tolerance induction. 
However, our results suggest that direct presentation of PTA 
in secondary lymphoid organs is a critically important process 
in subduing autoreactive T cells. Indeed, in situations where 
peripheral tolerance to a particular PTA is not mediated by 
conventional DC, such as Tyr369 (Nichols et al., 2007), LN 
stromal cell expression of PTA becomes vital to the deletion 
of self-reactive T cells. Because DCs that have acquired anti-
gen from tissue traffic only to local LN (Kurts et al., 1997; 
Hawiger et al., 2001; Hernandez et al., 2001; Vermaelen et al., 
2001; Belz et al., 2002; Scheinecker et al., 2002; Waithman 
et al., 2007), DC-mediated tolerance is limited. Conversely, 
PTA-expressing LN stromal cells are found in all LN, en-
abling systemic peripheral tolerance induction. This increases 
the likelihood that rare circulating autoreactive T cells will 
encounter a tolerizing APC. It will be fascinating to deter-
mine the relative contribution of DC versus LN stromal cell–
mediated peripheral tolerance.
MATERIALS AND METHODS
Mice. C57BL/6 mice carrying the AAD transgene or a fully deleted tyrosi-
nase gene (c38R145L) have been previously described (Newberg et al., 1996; 
Colella et al., 2000). FH mice were generated using TCR genes from a 
Tyr369-specific T cell clone derived from an AAD+ albino mouse (Nichols et al., 
2007). Aire/ mice were purchased from The Jackson Laboratory and bred 
the expression of Aire in these populations and demonstrates 
that expression of PTA in both LEC and FRC is controlled 
by an Aire-independent mechanism.
In this paper, we demonstrate that LN-resident LECs di-
rectly present an endogenous antigen to CD8 T cells. We 
previously demonstrated that FH T cell deletional tolerance 
is mediated by a radioresistant LN-resident cell and not 
through cross-presentation by DC (Nichols et al., 2007). Be-
cause LECs are the only cells in the LN that express tyrosi-
nase and present Tyr369 to induce FH T cell proliferation, we 
conclude that they are responsible for FH T cell deletion   
in vivo. It was initially surprising to find that LECs, rather 
than FRCs, express tyrosinase because FRCs form the stromal 
network of the T cell zone and interact extensively with naive 
T cells. However, our results also suggest that FRC and at 
least  two  other  LN-resident  populations  (gp38negCD31neg 
LN stromal cells and CD45+ LN cells) may also be involved 
in peripheral tolerance induction to different PTA. It will be 
of significant interest to determine the full breadth of PTA 
expression by these distinct subpopulations in comparison 
with one another to obtain a better understanding of their 
potential relevance in peripheral tolerance. It will also be of 
interest to determine how PTA expression patterns by LN 
populations compare with those of thymic mTECs to under-
stand the extent to which redundancy is built into central and 
peripheral tolerance pathways. It is significant that in the case 
of the Tyr369 epitope, tolerance is based on peripheral rather 
than  central  presentation,  despite  expression  of  tyrosinase 
mRNA in both LN and the thymus (Nichols et al., 2007). 
Thus, a full evaluation of this issue must be based on the 
availability of TCR transgenic models that enable an assess-
ment of tolerance to endogenous antigens.
Several recent studies have demonstrated direct expres-
sion of PTA in LN. Schuler et al. (2008) suggested that ex-
pression of several melanocyte differentiation proteins in LN 
was the result of a resident population of melanocytic lineage 
cells. However, we find that tyrosinase and Mart1 are pre-
dominantly expressed by LEC and FRC, respectively. Based 
on their surface markers and expression of gut and pancreatic 
PTA, neither of these cell types is of melanocytic origin. 
Gardner et al. (2008) demonstrated that peripheral tolerance 
to a transgenic antigen expressed under the control of the 
Aire promoter was mediated by a subset of EpCAM+ gp38neg 
LN stromal cells. Consistent with their work, we showed 
that both gp38negCD31neg LN stromal cells and CD45+ LN 
cells expressed Aire and that expression of the PTA Gad67 in 
both populations was strongly Aire dependent. It has also 
been reported that two tissue-specific transgenes, Gad67 and 
A33, were expressed in LN stromal cells that bind to the lec-
tin UEA-1 (Lee et al., 2007; Magnusson et al., 2008). How-
ever, this lectin stains 40–50% of LN stromal cells and is 
expressed on all of the subpopulations evaluated in this paper 
(unpublished data). Importantly, our results show that Gad67 
and A33 are actually expressed in distinct LN stromal sub-
populations. This emphasizes the importance of using more 
discriminating markers to clarify which LN stromal cell   JEM VOL. 207, April 12, 2010  687
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